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Experimental oral transmission of chronic wasting disease to red deer
(Cervus elaphus elaphus): Early detection and late stage distribution
of protease-resistant prion protein
Aru Balachandran, Noel P. Harrington, James Algire, Andrei Soutyrine, Terry R. Spraker,
Martin Jeffrey, Lorenzo González, Katherine I. O’Rourke
Abstract — Chronic wasting disease (CWD), an important emerging prion disease of cervids, is readily transmitted by intracerebral or oral inoculation from deer-to-deer and elk-to-elk, suggesting the latter is a natural route of
exposure. Studies of host range susceptibility to oral infection, particularly of those species found in habitats where
CWD currently exists are imperative. This report describes the experimental transmission of CWD to red deer
following oral inoculation with infectious CWD material of elk origin. At 18 to 20 months post-inoculation, mild
to moderate neurological signs and weight loss were observed and animals were euthanized and tested using 3 conventional immunological assays. The data indicate that red deer are susceptible to oral challenge and that tissues
currently used for CWD diagnosis show strong abnormal prion (PrP CWD) accumulation. Widespread peripheral
PrPCWD deposition involves lymphoreticular tissues, endocrine tissues, and cardiac muscle and suggests a potential
source of prion infectivity, a means of horizontal transmission and carrier state.
Résumé — Transmission orale expérimentale de la maladie du dépérissement chronique aux wapitis (Cervus
elaphus elaphus) : Dépistage précoce et répartition de la protéine du prion résistante à la protéase aux derniers
stades. La maladie du dépérissement chronique (MDC), une importante maladie à prions des cervidés qui est
émergente, se transmet facilement par inoculation intracérébrale ou orale d’un cerf à un cerf et d’un wapiti à un
wapiti, suggérant que cette dernière est une voie naturelle d’exposition. Des études sur l’ampleur de la susceptibilité
de l’hôte à l’infection orale, particulièrement chez les espèces trouvées dans des habitats où se trouve la MDC, sont
impératives. Ce rapport décrit la transmission expérimentale de la MDC aux wapitis après l’inoculation orale avec
des produits infectants de MDC provenant des wapitis. De 18 à 20 mois après l’inoculation, des signes
neurologiques de légers à modérés et la perte de poids ont été observés et les animaux ont été euthanasiés et testés
à l’aide de 3 essais immunologiques conventionnels. Les données indiquent que les wapitis sont susceptibles aux
infections défis orales et que les tissus actuellement utilisés pour le diagnostic de MDC montrent une accumulation
anormalement élevée de prions (PrP CWD). Un dépôt périphérique généralisé de PrP CWD vise les tissus
lymphoréticulaires, les tissus endocriniens et le muscle cardiaque et suggère une source potentielle d’infectivité des
prions, un mode de transmission horizontale et un état de porteur.
(Traduit par Isabelle Vallières)
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Introduction
Chronic wasting disease (CWD), a naturally occurring transmissible spongiform encephalopathy (TSE), is an enigmatic
and contagious prion disease of North American cervids that
has been described in both captive and free-ranging animals
including mule deer (Odocoileus hemionus), Rocky Mountain elk
(Cervus elaphus nelsoni), white-tailed deer (Odocoileus virginianus), and moose (Alces alces) (1). Chronic wasting disease shares
many clinical and pathologic features with scrapie of sheep and
goats, bovine spongiform encephalopathy (BSE), and transmissible mink encephalopathy (TME). However, CWD is unique
among the animal TSEs because it seems more contagious than
scrapie, BSE, or TME and is the only prion disease maintained
in free-ranging populations. A key event in the pathogenesis of
prion diseases, including CWD, is the conversion of a normal
host-encoded membrane associated prion protein (PrPC) to the
abnormal disease-associated isoform (PrPCWD) (2). It is generally believed that PrPCWD is the main or sole component of the
infectious agent, and that the accumulation of PrPCWD within
the central nervous system (CNS) is the primary event leading
to neurodegeneration (3).
The emergence of CWD amongst the North American commercial cervid industry, the detection of CWD in free-ranging
cervids over an increasingly wide geographic area, and the documented inter-species transmission between cervids, together,
raise the possibility that CWD will spread across the continent,
and perhaps beyond. Globally, farmed deer represent a significant alternative livestock industry with numbers exceeding
2 000 000 in New Zealand, 1 000 000 in China, 250 000 in the
United States, 400 000 in Russia, and 100 000 in Canada (4).
Red deer (Cervus elaphus elaphus), the Eurasian sub-species of
elk, were imported into Canada for the farming of venison and
antler in the late 1980’s and early 1990’s, and the captive cervid
industry subsequently generated red deer/elk hybrids in order
to increase the size of the red deer stock.
Among clinical CWD cases, the highest levels of prions are
found in the brain and spinal cord, but other tissues, particularly
those of the lymphoreticular system (LRS), exhibit substantial
disease associated PrPCWD accumulation (5). Currently, BSE is
the only animal TSE regarded as a zoonosis, whereas epidemiological evidence suggests that CWD has not been transmitted
to humans (6,7). Recent reports, however, have demonstrated
CWD infectivity in the skeletal muscle of experimentally
infected mice (8), hamsters (9), and deer (10). Because of the
presumed long incubation period of CWD, infectious prions
may be present in the peripheral tissues for a considerable period
of time before the onset of clinical signs. These findings have
raised concerns over the potential human health risks that may
be encountered by consuming CWD prion-contaminated meat
(11) and highlight the need for a thorough determination of
the distribution of CWD prions in peripheral tissues such as
skeletal muscle.
The diagnostic hallmark of CWD infection is the detection of PrPCWD accumulation in the CNS and LRS of affected
and preclinical animals. The medulla oblongata, at the level
of the obex, and the retropharyngeal lymph node are the
170

target tissues for CWD diagnosis of cervids. As a gold standard test, immunohistochemistry (IHC) is a sensitive and
effective technique for detecting CWD in cervids (12) but
is also a costly, labor-intensive, and time-consuming technique that requires skilled personnel. Laboratories conducting IHC may become overwhelmed by increasing demand to
support large-scale CWD and other TSE surveys. To address
these limitations, several rapid tests designed for large-volume
sample screening have been developed including enzymelinked immunosorbent assay (ELISA) and Western blotting
(WB) (13). However, the ability of such rapid tests to detect
PrPCWD in non-CNS and non-lymphoid tissues has not been
well described.
Although there has yet to be a reported case of natural transmission to red deer, there is concern of the spread of CWD to
this species and the potential for human exposure to cervid
PrPCWD. This paper describes the extent and distribution of
PrPCWD deposition in tissues from major organ systems of red
deer after oral inoculation with infectious CWD brain material.
Additional objectives were to evaluate lymphoid tissues from
antemortem pre-clinical deer for PrPCWD deposition, to compare the performance of IHC and ELISA for the detection of
PrPCWD in various CNS and non-CNS tissues, and to describe
PrPCWD Western blot glycoform patterns from infected tissues.
This knowledge will contribute to the understanding of CWD
pathogenesis in red deer and help in establishing diagnostic
methods for large-scale CWD surveillance. If CWD is found
to occur naturally in the future, this will form the basis of
consideration for limiting the spread of CWD from red deer
and for the protection against any potential spread of CWD
to humans.

Materials and methods
Experimental animals and CWD inoculum
Six 2-month-old captive red deer were obtained from herds
free from CWD and randomly assigned to inoculated (n = 4)
and control groups (n = 2). Inoculated deer were housed in
a Biosafety Level 2 isolation barn at the Ottawa Laboratory
Fallowfield, Canadian Food Inspection Agency (Ottawa,
Ontario). All experimental protocols were approved by the
institutional Animal Care Committee and were in accordance
with humane animal treatment requirements of the Canadian
Council on Animal Care.
Four red deer were orally inoculated with 5 mL of a tissue
homogenate created from a pool of 4 CWD-positive (by IHC
and ELISA) naturally infected captive Rocky Mountain elk.
The inoculum was prepared from brain (n = 4) tissues that
were placed in a mechanical grinder and a final homogenate
concentration of 40% (w/v) was made with physiological saline
resulting in an optical density for PrP CWD of 3.5 by ELISA
(TeSeE; Bio-Rad Laboratories, Hercules, California, USA). The
inoculum was administered using a small syringe inserted into
the diastema of the oral cavity. The infected deer were monitored
daily for clinical signs over the next 18 mo. Two non-infected
(sham-inoculated) control deer were housed separately but under
similar conditions to the CWD-inoculated deer.
CVJ / VOL 51 / FEBRUARY 2010

Sample collection for pre-clinical detection
of PrP CWD
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At 214 d post-inoculation, samples of nictitating membrane and
recto-anal mucosa associated lymphoid tissue were collected to
assess the infection status of the deer and to evaluate the utility
of such tissues for the pre-clinical detection of PrPCWD as previously described for sheep and other cervids (14,15).

Postmortem examination and tissue collection
When clinical signs of CWD (loss of appetite, loss of body condition, salivation, mild ataxia, weakness, dehydration, drooping
of head and ears) became evident in 2 of the 4 inoculated deer,
all animals were humanely euthanized with pentobarbital and
subjected to a complete postmortem examination (585 d PI).
Representative tissues from all major organ systems were collected including brain, cervical spinal cord (C1-C4), ganglia
(dorsal root and trigeminal), peripheral nerves (brachial plexus,
vagus, sciatic, facial, radial, and optic), digestive, respiratory,
cardiovascular, endocrine, musculoskeletal (triceps brachii,
trapezius, longissimus, semitendinosus, cardiac, lingual, masseter, and diaphragmatic muscles), urogenital, LRS (mesenteric,
ileocecal, sublumbar, popliteal, pre-scapular, retropharyngeal,
submandibular, parotid, ruminal, abomasal, hepatic, and prefemoral lymph nodes), and integument tissue. Duplicate samples
of tissue from adjacent areas were taken, one of which was fixed
in 10% neutral buffered formalin and the other stored frozen at
270°C. The fresh brain was cut longitudinally, 1/2 being fixed
in formalin and the remainder frozen at 270°C. The formalin
fixed brain was cut into coronal sections, 2 to 4 mm wide.
Eight brain areas per animal were selected for examination by
light microscopy including the rostral cerebrum (frontal lobe),
thalamus, midbrain (at 2 levels to include the superior colliculus
and red nucleus), pons, medulla (at the level of the cerebellar
peduncles and obex), and cerebellum at the vermis. Unfixed
tissue from contralateral brain areas were sampled by ELISA
and Western blot techniques.

Histopathology and immunohistochemistry
(IHC)
The techniques used for histopathology and IHC were similar
to those previously described (15,16). Tissues were embedded
in paraffin blocks, and serial sections were cut at 5-mm intervals
and mounted onto positively charged glass slides (Superfrost/
plus; Fisher Scientific, Ottawa, Ontario). The sections were
either stained with hematoxylin and eosin (HE) for the occurrence of spongiform degeneration (brain only), or subjected to
IHC for the presence of PrPCWD. Prior to IHC, antigen retrieval
was performed as follows: tissue sections were immersed in
96% formic acid (Mallinckrodt, Paris, Kentucky, USA) for
5 min, rinsed, and placed in 100 mM Tris buffer (pH 7.6)
for 25 min at 121°C (liquid setting) and cooled for 30 min to
room temperature. Subsequent steps of the IHC protocol were
performed with an automated immunostainer (Ventana Medical
Systems, Tucson, Arizona, USA). Sections were stained with
primary monoclonal antibody (MAb) F99/97.6.1 (VMRD,
Pullman, Washington, USA) for 30 min at 37°C, followed
by a biotinylated anti-mouse secondary antibody, an alkaline
CVJ / VOL 51 / FEBRUARY 2010

Figure 1. Immunohistochemistry (IHC) detection of PrPCWD in
rectal biopsy sample from a red deer (Cervus elaphus elaphus)
214 d after oral inoculation with infectious CWD material.
Lymphoid follicles beneath the rectal epithelium have variable
degrees of immunolabelling associated with tingible body
macrophages and follicular dendritic cells. Monoclonal antibody
F99/97.6.1 and hematoxylin counterstaining. Bar = 150 mm.

phosphatase-streptavidin conjugate, substrate chromogen (fast
red), and a hematoxylin counterstain with bluing (Ventana).
The primary antibody was diluted to an IgG concentration of
5 mg/mL in diluent (Ventana) and placed in the refillable dispenser provided with the immunostainer. Positive and negative
controls were included with each run.
Tissues that were positive by IHC had granular red chromogen deposits that were interpreted to be PrPCWD. The abundance
of PrPCWD was subjectively graded on a scale of 0 to 111
based on examination at 203, with 0 = no staining, 1 = mild,
11 = moderate, and 111 = strong. The intensity of the stain
was bright red whether the scoring was 1, 11, or 111. Since
the dorsal motor nucleus of the vagus (DMNV) was the most
consistently and severely affected nucleus with regard to the
abundance of IHC positive material, this nucleus was graded
as strong (111) and all other sites were scored accordingly.
Lymph nodes were considered positive if any of the follicles
exhibited positive IHC.

ELISA and Western blot
PrP CWD purification and immunodetection by ELISA and
Western blot were performed on unfixed tissue samples using
commercial test kists (TeSeE ELISA and TeSeE Western blot;
Bio-Rad) according to the manufacturer’s instructions, and as
previously described (17). For the ELISA, the absorbance cutoff value for PrPCWD detection was calculated by adding a fixed
value of 0.09 to the mean optical density of the negative controls (17). Western blot protein bands were identified, relative
intensities quantified, and their molecular mass estimated with
a Chemi Doc XRS (Bio-Rad) digital camera and the associated
analysis software (Quantity One, version 4.6, Bio-Rad). Positive
and negative control PrPCWD samples from CWD elk brain were
run on all Western blots throughout the study. Samples were
considered positive if the prion protein bands specific to the
PK-resistant core of PrPCWD were detected.
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Figure 2. Immunohistochemistry (IHC) detection of PrPCWD using MAb F99/97.6.1 in various tissues of orally
inoculated red deer (Cervus elaphus elaphus) with CWD.
(a) –	Brain, medulla oblongata, obex, dorsal motor nucleus of vagus nucleus. There is moderate diffuse vacuolation
of the neuropil and also occasional presence of vacuoles within neuronal perikarya. Hematoxylin & eosin.
Bar = 30 mm.
(b) –	Brain, medulla oblongata, obex. There is extensive accumulation of PrPCWD (stained red) predominantly in the
neuropil and with prominent perineuronal labelling. IHC. Bar = 70 mm.
(c) – Tonsil. Detection of PrPCWD in tonsillar lymphoid follicles. IHC. Bar = 275 mm.
(d) – Colon, myenteric plexus. IHC. Bar = 70 mm.
(e) – Adrenal gland, medulla. IHC. Bar = 70 mm.
(f) – Heart, ventricular septum. IHC. Bar = 40 mm.
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Table 1. PrP CWD distribution and comparative subjective assessment of the signal intensities of immunohistochemistry (IHC) and enzymelinked immunosorbent assay (ELISA) from different brain and spinal cord regions from 4 orally inoculated CWD-positive red deer (Cervus
elaphus elaphus)
Spinal cordb

Brainstem

Cerebellum

Midbrain

Thalamus

Cerebrum

IHCc

ELISAd

IHC

ELISA

IHC

ELISA

IHC

ELISA

IHC

ELISA

IHC

ELISA

101
103a
105a
106

111
111
111
111

3.226
2.570
3.165
3.227

111
111
111
111

. 3.5
2.749
3.042
. 3.5

111
111
111
11

3.016
2.543
2.331
1.362

111
11
111
111

. 3.5
2.739
3.014
3.434

111
11
111
111

. 3.5
2.866
2.995
. 3.5

11
111
111
11

1.983
2.614
3.010
1.736

a

Animals no. 103 and 105 developed clinical signs at 576 and 583 d post-inoculation, respectively. All deer were subsequently euthanized and subjected to postmortem
examination and PrPCWD testing.
b Sample of cervical spinal cord (C1-C4).
c PrPCWD was detected by IHC with MAb F99/97.6.6 with the scoring system (1 to 111) described in Materials and methods.
d Optical density (OD) data from Bio-Rad Laboratories’ ELISA.

PRNP genotyping
Genomic DNA from blood or tissue samples of experimental red
deer was subject to PCR amplification and sequence analysis of
the PRNP open reading frame as described for Rocky Mountain
elk (18).

Results
Pre-clinical detection of PrP CWD
Samples of nictitating membrane collected at 214 d PI were
negative by IHC and ELISA for all infected deer. Rectal lymphoid tissue collected at the same time was positive for PrPCWD
by IHC (Figure 1) but negative by ELISA for all infected deer.

Clinical signs and postmortem examination
At 576 d PI, one of the inoculated deer (No. 103) began to show
subtle variable clinical signs consistent with CWD. Abnormal
neurological signs included ataxia, hyperexcitability, trembling,
weakness, isolation, standing with lowered head, and hypersalivation. The affected animal consumed reduced amounts of
feed leading to a gradual loss of body condition. After a second
infected deer (No. 105) began to show similar clinical signs at
583 d PI, all deer were euthanized and subject to postmortem
examination. The primary gross lesions were emaciation accompanied by generalized absence or serous atrophy of subcutaneous and abdominal adipose tissue and yellow gelatinous bone
marrow. All inoculated animals were otherwise normal and no
lesions were found in control deer.

Histopathology
Spongiform encephalopathy was observed in the brain of the
4 infected deer and was characterized by severe and widespread
microcavitation primarily of the grey matter, single or multiple
intracytoplasmic vacuolation of neurons, neuronal degeneration
and loss, mild astrocytic hypertrophy and hyperplasia, and the
absence of any significant inflammatory response (Figure 2a).
The severity of spongiform change varied in the grey matter of
the medulla oblongata, pons, thalamus, and cerebral cortex.
Specific areas consistently most severely affected included olfactory bulbs, thalamic nucleus, supraoptic nucleus, paraventricular
nucleus, reticular formation, hypoglossal nucleus, parasympathetic nucleus nucleus of the vagus nerve, medial and lateral
cuneatus nuclei, and nucleus of the spinal tract of the trigeminal
CVJ / VOL 51 / FEBRUARY 2010

nerve. No lesions suggestive of spongiform encephalopathy were
seen in the control deer.

Tissue distribution of PrP CWD by IHC and ELISA
The results of a comparative assessment of PrPCWD signal intensity obtained by IHC and the ELISA rapid test for various brain
and spinal cord areas are shown in Table 1. Both tests detected
high levels of PrPCWD from all areas of the brain and spinal
cord. The pattern of staining was consistent amongst inoculated
animals. The immunolabeling pattern consisted of coarse, granular, or particulate deposits of red chromogen. The labelled foci
were located primarily in grey matter, but sometimes appeared
in white matter, especially in the rostral cerebrum. The location of PrPCWD was often perineuronal, forming a ring around
the cell (Figure 2b). Neuropil accumulations were of the fine
particulate type, with some more coarse and linear deposits in
severely affected areas. The most severely affected brain areas
were the midbrain and medulla where foci were so numerous
and large that they often formed large confluent areas. Granular
deposits of PrPCWD within the cytoplasm of neurons were
prominent, especially throughout the brainstem and thalamic
nuclei. Intracellular deposits of PrPCWD were also noticeable
in astrocytes and microglial cells in areas of heavy neuropil
involvement. In the spinal cord, fine punctuate or coarse particulate neuropil-type accumulation of PrP CWD was greatest in
the dorsal horns but at reduced levels as compared to the brain.
The eyes of affected deer had consistent PrPCWD distribution by
IHC in the optic nerve fibers, the layer of ganglion cells, and
the inner and outer plexiform layers of the retina. The ELISA
detected PrPCWD from the adjacently sampled ocular areas in
3 of 4 CWD infected deer.
In addition to the CNS, PrPCWD was detected by IHC and
ELISA in a variety of other tissues including lymphoid tissue,
nerve ganglia (trigeminal and dorsal root), endocrine tissues
(adrenal gland, pancreas, and pars nervosa of the pituitary
gland), cardiac muscle, the myenteric plexus of most gastrointestinal tissues, and nasal mucosa (Table 2).
Chromogen staining consistent with PrPCWD was observed in
the germinal centers of the tonsil, gut-associated lymphoid tissue
(GALT), and all lymph nodes. The PrPCWD deposition was characterized by bright red granular material filling germinal centers
of 50% to 95% of follicles (Figure 2c). The staining pattern was
173

A R T I C LE

Animala
ID

Table 2. Comparison of immunohistochemical (IHC) staining and enzyme-linked immunosorbent assay
(ELISA) detection of PrP CWD in selected tissues from 4 orally-inoculated CWD-positive red deer
(Cervus elaphus elaphus)
Detection
of PrPCWD
System, anatomical sites

ELISA

IHCa

Detection
of PrPCWD
System, anatomical sites

A R T I C LE

Central nervous system			  Pre-femoral LN
Eye
3/4b
4/4	  Popliteal LN
Cervical spinal cord (C1-C3):
4/4
4/4	  Spleen
Medulla (at obex)
4/4
4/4	  Tonsil
Rostral medulla
4/4
4/4
Digestive system
Midbrain
4/4
4/4	  Submandibular salivary gland
Thalamus
4/4
4/4	  Parotid salivary gland
Frontal cortex
4/4
4/4	  Reticulum
Cerebellum/vermis
4/4
4/4	  Rumen
Peripheral nervous system			  Abomasum
Trigeminal ganglia
1/4
4/4	  Duodenum
Dorsal root ganglia
0/3c
3/3	  Jejunum
Sympathetic trunk
0/4
0/4	  Ileum
Vagus nerve
0/4
0/4	  Proximal Colon
Sciatic nerve
0/4
0/4	  Distal Colon
Radial nerve
0/4
0/4
Respiratory system
Facial nerve
0/4
0/4	  Nasal mucosa
Brachial plexus
0/4
0/4	  Lung
Lymphoreticular system			
Endocrine system
Rectal lymphoid tissue
2/4
4/4	  Pancreas
Peyer’s Patches
3/4
4/4	  Thyroid Gland
Retropharyngeal LN
3/4
4/4	  Adrenal Gland
Parotid LN
3/4
4/4	  Pituitary Gland
Submandibular LN
3/4
4/4
Musculoskeletal system
Pre-Scapular LN
1/4
3/4	  Diaphragm
Hepatic LN
3/4
4/4	  Masseter muscle
Ruminal LN
3/3
3/4	  Triceps brachii muscle
Abomasal LN
3/3
3/3	  Longissimus thoracis muscle
Mesenteric LN
4/4
4/4	  Semitendinosus muscle
Ileocecal LN
4/4
4/4
Sublumbar LN
2/3
3/3	  Heart

ELISA

IHC

1/4
4/4
3/4
3/4

3/4
3/4
3/4
4/4

2/4
2/4
3/4
0/4
1/4
2/3
0/4
4/4
3/4
1/4

0/4
1/4
4/4
2/4
4/4
3/3
4/4
4/4
4/4
4/4

3/3
0/4

2/4
0/4

1/4
0/4
3/3
4/4

2/4
1/4
3/3
4/4

0/4
0/4
0/4
0/4
0/4

0/4
0/4
0/4
0/4
0/4

2/4

4/4

a

PrPCWD was detected by IHC with MAb F99/97.6.6.
b Results are expressed as the number of test positive animals over the total number of animals examined.
c Some tissues were not available for examination.
LN = lymph node.

morphologically consistent with that of follicular dendritic cells
within germinal centers of well-developed secondary follicles.
Staining often occurred in clusters of adjacent follicles.
The ELISA results were in general agreement with IHC
results, but were slightly less sensitive. Of 62 lymphoid tissues
tested, ELISA and IHC classified 42 and 57 tissues as positive,
respectively. PrPCWD was detected from each lymph node in at
least 1 animal. For tissues reported to have potential preclinical
CWD diagnostic utility, IHC detected PrP CWD in tonsil and
rectal lymphoid tissue from all inoculated deer whereas ELISA
classified 3 of 4 tonsil and 1 of 4 rectal lymphoid tissues as
CWD positive.
Positive IHC and ELISA results were found in virtually all
gastrointestinal tissues including the parotid and mandibular
salivary glands, the myenteric plexus of rumen, abomasum, small
intestine, ileum, and colon. Deposition of PrPCWD was located
in the GALT with a pattern analogous to other lymphoid follicles. Perineuronal staining was present within the submucosal
and myenteric plexuses (Figure 2d).
Positive IHC and ELISA results were found in several neuroendocrine tissues including the pancreas, thyroid, adrenal, and
pituitary glands. The pancreas of 2 of 4 CWD-positive deer contained coarse granular PrPCWD deposits confined to the islets of
174

Langerhans. One of these deer was also classified as positive by
ELISA. One animal had PrPCWD detected in the thyroid gland
with deposits located along the apical surface of parafollicular
cells. In the pituitary glands of all CWD-positive deer (IHC
and ELISA), PrPCWD deposits were evident, primarily in the
pars nervosa and intermedia. Similarly, PrPCWD was detected in
the adrenal glands of 3 deer by IHC and ELISA. Staining was
restricted to the medulla where large columnar cells appeared to
have PrPCWD deposits intracellularly and associated with the cell
surface (Figure 2e). The PrPCWD deposits were large and angular
as opposed to small and granular as reported in other tissues.
The ventricular myocardium of all 4 infected deer showed
PrP CWD deposition consisting of readily visible punctuate
granules of chromogen scattered in apparently cell-associated
fashion more prominent in longitudinal than in transverse
cross-sections of cardiac myocytes. Groups of positive adjacent
myocytes were surrounded by cells with no detectable stain
(Figure 2f ). Epicardial nerves and ganglia and subendocardial
and myocardial Purkinje fibers lacked detectable PrPCWD staining. Cardiac muscle was also strongly positive by ELISA in 2 of
4 inoculated deer (Table 2).
Of the respiratory tissues, only the nasal mucosa was ELISA
and IHC positive for PrPCWD. No PrPCWD was detected by IHC
CVJ / VOL 51 / FEBRUARY 2010
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Figure 3. Western blot analysis of the prion protein proteinase K-resistant core (PrPres of PrPCWD) from
the homogenates of the medulla oblongata of orally inoculated red deer (Cervus elaphus elaphus). The
positive banding pattern of 4 red deer samples (deer no. 101, 103, 105, and 106 in triplicate) is compared
with that of a previously characterized positive control sample from a captive CWD-affected elk. Animals
no. 103 and 105 developed clinical signs at 576 and 583 days post-inoculation respectively. All deer were
subsequently euthanized and subject to post-mortem examination and PrPCWD testing. Protein molecular
weight (MW) markers are shown on the left in kilodaltons. A negative control sample is shown on the right
(deer no. 104).

or ELISA in the following tissues: skeletal striated muscle, kidney, urinary bladder, ovary, uterus, and testis. In addition, no
PrPCWD was detected in any tissue of control deer.

Western blot
Western blot analysis was performed on selected samples including brainstem, skeletal muscle, cardiac muscle, adrenal gland,
pancreas, thyroid gland, and nasal mucosa. For the brainstem,
tissue was taken and homogenates prepared from the medulla
contralateral to the section taken for IHC. The brainstem of
all inoculated deer was positive by this method, showing the
characteristic banding pattern of the TSEs (Figure 3). The profiles of 3 bands of proteinase K-resistant isoforms of PrP CWD,
di-, mono-, and unglycosylated, were comparable in molecular
weight and glycoform ratio to those of the original inoculum.
The 2 control deer had no detectable PrPCWD in the brainstem
by Western blot.
The Western blot findings were consistent with IHC and
ELISA for PrPCWD detection in selected extraneural tissues
including cardiac muscle, pancreas, thyroid, and adrenal gland.
For example, the adrenal glands, which demonstrated abundant PrPCWD by IHC and ELISA, also showed strong banding
pattern signals by Western blot. In contrast, we were unable
to demonstrate the presence of PrPCWD in the skeletal striated
muscle of any deer.

PRNP genotype
The DNA sequence of the open reading frame of the PRNP gene
from the 4 inoculated red deer in this study was similar to that
reported previously for C. elaphus elaphus, with a single coding
polymorphism (glutamic acid E and glutamine Q) at codon 226
(GenBank P67987 and AY748455) (19) with a synonymous
change (GCC to GCT) at codon 106 on the allele encoding
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226Q. Samples from all 4 animals encoded methionine at
codon 132, glycine at codon 96, and serine at codon 225, sites
associated with prion disease progression in Rocky Mountain
elk, white-tailed deer, and mule deer, respectively. Red deer 105
was homozygous for 226E, red deer 106 was homozygous for
226Q, and red deer 101 and 103 were heterozygous for the nonsynonymous (226EQ) and synonymous (106 gcc/gct) changes.

Discussion
Until recently, only 3 species, all members of the Family
Cervidae, were known to be naturally susceptible to CWD,
namely: mule deer, white-tailed deer, and Rocky Mountain elk.
In 2005, however, a free-ranging moose (Alces alces) was found
to be infected with CWD (20) and moose were shown to be
susceptible to experimental CWD (21). Although a natural
case CWD infection has yet to be reported for red deer, this
study indicates that the potential for it to occur exists. This was
expected given that elk and red deer are of the same genus and
species (Cervus elaphus).
As with other TSEs, CWD is characterized by a long incubation period which, in deer, is seldom less than 18 mo. Although
only subtle clinical signs of CWD were evident in 2 of 4 inoculated animals, the neurological lesions were quite obvious histologically for all 4 deer. The distribution and severity of these
lesions were consistent with those previously reported for CWD
in other cervid species (22,23) and qualitatively similar to those
described for the other spongiform encephalopathies (24).
Immunohistochemistry has demonstrated the accumulation
of CWD-specific prion protein in the brain, spinal cord, nerves,
and ganglia of the peripheral nervous system, lymphoid tissues,
and in endocrine tissues of clinical cases (25,26). This study
demonstrates that red deer develop detectable PrPCWD after oral
exposure to an inoculum containing CWD prions and provides
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knowledge about the tissue pattern of PrPCWD accumulation at
the terminal stages of disease. The pattern of PrP CWD deposition in the brain was consistent with previous descriptions of
naturally CWD-infected cervids (23,27). PrP CWD deposition
was observed in all areas of spongiform encephalopathy, but in
many areas where PrPCWD was present, spongiform degeneration was not found.
The PrPCWD was deposited in follicles of almost all lymphoid
tissues, including those of the digestive tract, tonsil, and lymph
nodes as has been shown to be the case for other CWD-infected
cervids (23), and scrapie-infected sheep and goats (28,29).
Sigurdson et al (30) demonstrated PrPCWD in tonsil and alimentary tract-associated lymphoid tissues of mule deer fawns as early
as 42 d after they were orally inoculated with brain tissue from
captive deer dying of CWD. The pre-clinical detection PrPCWD
and the abundance of PrPCWD in the lymphoid tissues at postmortem in the present study suggest that lymphoid tissues of
this species may play a role in the pathogenesis and transmission.
Such disseminated lymphoid infection contrasts with some other
TSEs, such as BSE, in which PrPBSE is detected only in the ileal
Peyer’s patches or not at all (31). Similarly, recent experimental
transmission of BSE to red deer found PrPBSE restricted to the
central and peripheral nervous systems (32).
There is a strong correlation between the presence of PrP TSE
and infectivity in prion diseases. Although the epidemiologic
evidence strongly suggests that CWD is not transmissible to
humans, this study and others suggest caution in this regard.
The finding of PrPCWD in various organs, albeit in clinical
CWD, suggests that humans who consume or handle meat from
CWD-infected red deer may be at risk of exposure to CWD
prions. This study found that red deer tissues other than nervous and lymphoid tissue can support CWD prion replication
and accumulation. As a result, the consumption or handling
of meat from CWD-infected red deer will put humans at risk
of exposure to CWD prions. In spite of a well-documented
species barrier, a cautious approach would involve preventing
such tissues from entering the animal and human food chains.
Future studies will require sensitive and quantitative techniques
such as bioassays in transgenic mice that assess tissue infectivity
and quantitative immunoassays adapted to PrPCWD detection in
peripheral tissues.
The presence of PrPCWD in the left ventricular myocardium
was probably due to dissemination by peripheral nerves, as this
phenomenon has also been observed in CWD-infected mule
deer, white-tailed deer, and elk (33,34). It is not known whether
the prions that were detected in cardiac tissue were localized to
nerve fibers or subcellular structures within myocytes.
Substantial deposits of PrPCWD were detected by IHC and
ELISA in the adrenal medulla and pancreatic islet cells, and
lesser amounts in the thyroid gland. Infectivity in the pancreas
and adrenal medulla, which are innervated by splanchnic nerves
and the vagus nerve, respectively, has been documented in
natural and experimentally infected scrapie and CWD (25,35).
PrP-containing islet cells and glandular cells of the adrenal
medulla were often adjacent, which might suggest infection
from a common nidus, such as innervation by a common nerve
branch. Although PrPCWD has not been reported previously in
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the thyroid gland, the normal cellular isoform of prion protein
(PrPC) has (36), indicative of the potential for conversion to
PrPCWD. We also documented PrPCWD in the pars intermedia and nervosa of the pituitary in CWD-infected red deer.
Potentially, PrPCWD could transit via nerve fibers from the hypothalamus to the pars nervosa, as the deer had abundant PrPCWD
in the hypothalamus. Given the recent report demonstrating
CWD infectivity of skeletal muscle tissue when inoculated into
transgenic mice (10), the present study rigorously tested for
PrPCWD deposits in the skeletal muscles of inoculated red deer.
Importantly, no PrPCWD deposition was detected in any striated skeletal muscle using conventional methods. This finding
corroborates similar negative observations in cervids made by
others (26,33,37). Cardiac muscle differs from skeletal muscle
in its structure, physiology, and innervation; one or more of
these factors may underlie the difference in PrPCWD deposition
between skeletal and cardiac muscle for cervids. Glatzel et al (38)
proposed a positive correlation between the duration of disease
and the detection of PrPCWD in muscle. A longer duration of
clinical disease, therefore, may have increased the likelihood of
detecting PrPCWD in muscle.
The exact mode of transmission of CWD in nature remains
unclear but is believed to involve direct animal-to-animal
contact or environmental contamination. As TSE agents are
extremely resistant in the environment (39), oral exposure is
the most plausible pathway by which the CWD prion may be
introduced to deer in nature and represents a significant obstacle
to eradication of CWD from either farmed or free-ranging cervid populations. The distribution of PrP CWD in gut-associated
lymphoid tissues, salivary glands, and nasal mucosa in the red
deer of this study suggests potential routes of PrPCWD shedding
into the environment via fluids such as saliva or feces. However,
this study did not identify the point at which an animal may
become infectious during the course of infection. An improved
understanding of the mechanisms of shedding and transmission
will be important in the future management of CWD.
The general pattern of PrP CWD accumulation in cervids
with CWD is characterized by relatively rapid and widespread
involvement of lymphatic tissues, followed by progressive
involvement of, and lesions in, central and peripheral nervous
tissues, with involvement of a wider variety of tissues and
organs as animals become terminally ill (34). Assuming the
immunobiology of red deer is similar to that of other cervids
and sheep, it seems probable that initial uptake and propagation
of PrPCWD may occur in the lymphoid tissues draining the oral
and intestinal mucosa (the retropharyngeal lymph nodes, tonsil,
ileal Peyer’s patches, and ileocecal lymph nodes). The finding of
PrPCWD in rectal lymphoid tissues as early as 7 months PI supports such a model for red deer.
The appearance of PrPCWD in myenteric and submucosal
plexuses of the gastrointestinal tract and in brain and spinal
cord is consistent with the hypothesis that autonomic innervations, particularly of enteric tissues, plays a role in the spread
of PrPCWD from peripheral tissues to the CNS (25,40). The
gastrointestinal tract receives parasympathetic vagal fibers from
the DMNV and sympathetic nerve fibers from the spinal cord.
PrPCWD was not detected either by ELISA, IHC or Western blot
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species as well as strain differences for particular TSEs (43,44).
Western blot of the brainstem of all CWD-inoculated red deer
demonstrated a glycoform banding pattern identical to that of
the tested extraneural tissues and the inoculum prepared from
previously characterized captive elk (Figure 3).
The primary sequence of the prion protein precursor is associated with prevalence, incubation time, and proteolytic cleavage
sites in some cervid species exposed to CWD. A polymorphism
(methionine M to leucine L) at PRNP codon 132 is associated
with increased incubation time and a novel protease cleavage site in PrPCWD of Rocky Mountain elk with experimental
disease and in a transgenic rodent model (45,46), although its
association with CWD prevalence varies (47). A coding change
was identified at codon 226, which encodes glutamic acid (E)
in C. elaphus canadensis (48) and C. elaphus nelsoni (49) and
glutamine (Q) in Hemionus spp. in North America. The site
is polymorphic in red deer [(19) and unpublished data shown
in GenBank AY748455] and all 3 diploid genotypes (EE, QQ,
EQ) were represented in this study. There were no differences
in Western blot profile or incubation time associated with these
genotypes. If the effect of genotype on natural disease is similar
to that observed in this study, the polymorphism is unlikely to
affect disease progression or diagnostic testing.
In summary, this study demonstrates the potential for oral
transmission of CWD to red deer and describes the pattern
of PrPCWD accumulation for this species. The current surveillance testing regime for cervids would be expected to identify
CWD-infected red deer should it occur in North America.
These results confirm the usefulness of rapid tests such as
ELISA but with generally slightly lower sensitivity when compared with IHC when testing tissues with patchy or sporadic
PrPCWD deposition. The finding of PrPCWD in several extraneural tissues including cardiac muscle and the endocrine
system suggests that further investigation and monitoring of
the potential transmissibility to other species including humans
is warranted.
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